MKN45
Resource Report
Resource Website
500+ mentions
|
RRID:CVCL_0434
|
Homo sapiens (Human)
|
Gastric adenocarcinoma
|
Caution: Was indicated not to have a TP53 mutation in PubMed=1370612 and PubMed=15900046., Characteristics: MET-amplified, contains 12-13 copies of the gene (PubMed=29435981)., Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: JFCR45 cancer cell line panel., Part of: JFCR39 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:758928 PMID:1370612 PMID:1486568 PMID:1778766 PMID:1846553 PMID:1933850 PMID:2061947 PMID:2105279 PMID:3962675 PMID:3986962 PMID:6862145 PMID:9023415 PMID:9247707 PMID:9290701 PMID:9665481 PMID:11107048 PMID:11314020 PMID:11668190 PMID:15723654 PMID:15767549 PMID:15900046 PMID:15901131 PMID:18804159 PMID:20164919 PMID:20215515 PMID:22336246 PMID:22460905 PMID:22531121 PMID:23671654 PMID:24587255 PMID:24807215 PMID:25343454 PMID:25485619 PMID:25877200 PMID:25960936 PMID:26589293 PMID:27397505 PMID:28196595 PMID:29435981 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
MKN-45, MKN 45 |
|
|
BTO:BTO_0001225, CLO:CLO_0007733, CLO:CLO_0050797, EFO:EFO_0002832, MCCL:MCC:0000329, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:404, BioSample:SAMN03473237, BioSample:SAMN03473585, BioSample:SAMN10988555, cancercelllines:CVCL_0434, CCRID:1101HUM-PUMC000229, CCTCC:GDC0220, Cell_Model_Passport:SIDM00247, CGH-DB:120-1, CGH-DB:9022-4, ChEMBL-Cells:CHEMBL3307603, ChEMBL-Targets:CHEMBL614354, CLS:300489, Cosmic:685596, Cosmic:801339, Cosmic:848147, Cosmic:848373, Cosmic:873711, Cosmic:877042, Cosmic:887256, Cosmic:888827, Cosmic:897535, Cosmic:918497, Cosmic:922696, Cosmic:925340, Cosmic:926114, Cosmic:968349, Cosmic:983727, Cosmic:1001651, Cosmic:1001655, Cosmic:1007602, Cosmic:1090461, Cosmic:1093299, Cosmic:1187283, Cosmic:1223589, Cosmic:1329185, Cosmic:1436026, Cosmic:1460707, Cosmic:1518241, Cosmic:1518255, Cosmic:1582430, Cosmic:1627265, Cosmic:1995510, Cosmic:2036663, Cosmic:2807633, Cosmic:2823225, Cosmic-CLP:925340, DepMap:ACH-000356, DSMZ:ACC-409, DSMZCellDive:ACC-409, EGA:EGAS00001000610, EGA:EGAS00001000978, FANTOM5_SSTAR:10612-108F9, GDSC:925340, GEO:GSM552364, GEO:GSM562395, GEO:GSM618013, GEO:GSM618014, GEO:GSM618015, GEO:GSM618016, GEO:GSM827532, GEO:GSM828836, GEO:GSM844607, GEO:GSM887324, GEO:GSM888400, GEO:GSM1374681, GEO:GSM1670113, IARC_TP53:21633, IARC_TP53:30213, IBRC:C10137, JCRB:JCRB0254, KCLB:80103, LiGeA:CCLE_725, LINCS_LDP:LCL-1535, NCBI_Iran:C615, PharmacoDB:MKN45_938_2019, PRIDE:PXD030304, Progenetix:CVCL_0434, PubChem_Cell_line:CVCL_0434, RCB:RCB1001, Wikidata:Q28473066 |
|
|
CVCL_0434 |
2026-08-29 04:46:33 |
974 |
MM1.S
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_8792
|
Homo sapiens (Human)
|
Plasma cell myeloma
|
Characteristics: Sensitive to dexamethasone., Characteristics: Produces IgA lambda (ATCC=CRL-2974)., Population: African American., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:12691914 PMID:14760100 PMID:16956823 PMID:17692805 PMID:18647998 PMID:21173094 PMID:22460905 PMID:25485619 PMID:25688540 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30285677 PMID:30545397 PMID:30894373 PMID:30971826 PMID:31068700 PMID:32123307 PMID:35839778
|
Cancer cell line
|
Female |
MM.1S, MM1-S, MM-1S, MM1S |
|
|
BTO:BTO_0003933, CLO:CLO_0037203, EFO:EFO_0005724, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-TABM-1088, ATCC:CRL-2974, BioGRID_ORCS_Cell_line:801, BioSample:SAMN03471684, BioSample:SAMN10988254, cancercelllines:CVCL_8792, CCRID:1101HUM-PUMC000680, CCRID:3101HUMSCSP5017, Cell_Model_Passport:SIDM01265, ChEMBL-Cells:CHEMBL4295490, ChEMBL-Targets:CHEMBL4296471, CLS:305304, Cosmic:1424218, Cosmic:1483077, Cosmic:1762460, Cosmic:1889512, Cosmic:2081430, Cosmic:2391805, Cosmic:2809756, Cosmic-CLP:1659818, DepMap:ACH-000763, EGA:EGAS00001000610, EGA:EGAS00001000978, ENCODE:ENCBS205VYW, ENCODE:ENCBS241TLI, ENCODE:ENCBS299YQN, ENCODE:ENCBS523NFL, ENCODE:ENCBS981ZAE, GDSC:1659818, GEO:GSM562814, GEO:GSM887328, GEO:GSM888404, GEO:GSM1374685, GEO:GSM1666388, GEO:GSM1670118, IARC_TP53:28513, IZSLER:BS TCL 237, LiGeA:CCLE_132, Lonza:168, PharmacoDB:MM1S_944_2019, PRIDE:PXD021265, PRIDE:PXD030304, Progenetix:CVCL_8792, PubChem_Cell_line:CVCL_8792, Wikidata:Q54906038 |
cvcl_5801 |
|
CVCL_8792 |
2026-08-29 04:46:41 |
261 |
Ku812
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_0379
|
Homo sapiens (Human)
|
Chronic myelogenous leukemia, BCR-ABL1 positive
|
Population: Japanese., Part of: LL-100 blood cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2540861 PMID:3332852 PMID:3858609 PMID:9290701 PMID:9510473 PMID:9644295 PMID:10071072 PMID:10576511 PMID:11264164 PMID:11416159 PMID:15843827 PMID:16408098 PMID:20164919 PMID:20215515 PMID:20809971 PMID:22460905 PMID:25149487 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:31160637 PMID:35839778
|
Cancer cell line
|
Male |
KU812, KU-812, KU.812, KU 812 |
|
|
BTO:BTO_0000732, CLO:CLO_0007124, CLO:CLO_0007125, CLO:CLO_0050989, EFO:EFO_0002222, MCCL:MCC:0000274, CLDB:cl3070, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, ATCC:CRL-2099, BCRC:60502, BCRJ:0261, BioSample:SAMN01821693, BioSample:SAMN01821733, BioSample:SAMN03472893, BioSample:SAMN10988528, cancercelllines:CVCL_0379, CCRID:1101HUM-PUMC000522, CCRID:3101HUMTCHu189, Cell_Model_Passport:SIDM00308, CGH-DB:9211-4, ChEMBL-Cells:CHEMBL3308504, ChEMBL-Targets:CHEMBL613997, CLS:305306, Cosmic:787498, Cosmic:907311, Cosmic:919119, Cosmic:922163, Cosmic:924052, Cosmic:949096, Cosmic:991560, Cosmic:999778, Cosmic:1012080, Cosmic:1026568, Cosmic:1067444, Cosmic:1078716, Cosmic:1519164, Cosmic:2009518, Cosmic-CLP:907311, DepMap:ACH-000074, DSMZ:ACC-378, DSMZCellDive:ACC-378, ECACC:90071807, EGA:EGAS00001000610, EGA:EGAS00001000978, FANTOM5_SSTAR:10409-106B4, GDSC:907311, GEO:GSM887244, GEO:GSM888318, GEO:GSM1374606, GEO:GSM1670011, IARC_TP53:342, IARC_TP53:21446, IGRhCellID:KU812, JCRB:IFO50363, JCRB:JCRB0104, LiGeA:CCLE_172, LINCS_LDP:LCL-1106, Lonza:1207, PharmacoDB:KU812_795_2019, PRIDE:PXD030304, Progenetix:CVCL_0379, PubChem_Cell_line:CVCL_0379, RCB:RCB0495, Wikidata:Q54900693 |
|
|
CVCL_0379 |
2026-08-29 04:44:33 |
8 |
Kuramochi
Resource Report
Resource Website
50+ mentions
|
RRID:CVCL_1345
|
Homo sapiens (Human)
|
High grade ovarian serous adenocarcinoma
|
Population: Japanese., Part of: TCGA-110-CL cell line panel., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:6268719 PMID:7069245 PMID:9290701 PMID:11330945 PMID:12417041 PMID:20164919 PMID:22460905 PMID:23839242 PMID:24023729 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27397505 PMID:27561551 PMID:28196595 PMID:30485824 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31395879 PMID:31978347 PMID:32612269 PMID:35839778
|
Cancer cell line
|
Female |
KURAMOCHI |
|
|
CLO:CLO_0037093, EFO:EFO_0006625, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:578, BioSample:SAMN03471055, BioSample:SAMN10988052, cancercelllines:CVCL_1345, Cell_Model_Passport:SIDM00554, CGH-DB:9357-4, ChEMBL-Cells:CHEMBL3308307, ChEMBL-Targets:CHEMBL2366119, Cosmic:809116, Cosmic:909975, Cosmic:931364, Cosmic-CLP:909975, DepMap:ACH-000524, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:909975, GEO:GSM186430, GEO:GSM186431, GEO:GSM659381, GEO:GSM888319, GEO:GSM1670012, IARC_TP53:1415, JCRB:JCRB0098, LiGeA:CCLE_899, LINCS_LDP:LCL-1701, PharmacoDB:KURAMOCHI_796_2019, PRIDE:PXD003668, PRIDE:PXD030304, Progenetix:CVCL_1345, PubChem_Cell_line:CVCL_1345, Wikidata:Q54900722 |
|
|
CVCL_1345 |
2026-08-29 04:44:34 |
52 |
KYSE-450
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_1353
|
Homo sapiens (Human)
|
Esophageal squamous cell carcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1728357 PMID:7913084 PMID:8575860 PMID:9033652 PMID:11092977 PMID:15172977 PMID:16045545 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26512696 PMID:26589293 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
KYSE 450, KYSE450, Kyse450 |
|
|
CLO:CLO_0007134, EFO:EFO_0006630, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:574, BioSample:SAMN03471051, BioSample:SAMN10987615, cancercelllines:CVCL_1353, Cell_Model_Passport:SIDM01027, CGH-DB:287-1, CGH-DB:9236-4, ChEMBL-Cells:CHEMBL3308755, ChEMBL-Targets:CHEMBL1075488, Cosmic:801334, Cosmic:907320, Cosmic:918534, Cosmic:983846, Cosmic:1123342, Cosmic:1339910, Cosmic:2267702, Cosmic:2395005, Cosmic:2650635, Cosmic:2698443, Cosmic-CLP:907320, DepMap:ACH-000865, DSMZ:ACC-387, DSMZCellDive:ACC-387, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:907320, GEO:GSM827540, GEO:GSM887253, GEO:GSM888328, GEO:GSM1374612, GEO:GSM1670022, IARC_TP53:7685, IARC_TP53:21452, JCRB:JCRB1430, LiGeA:CCLE_901, LINCS_HMS:50027, LINCS_LDP:LCL-1550, PharmacoDB:KYSE450_808_2019, PRIDE:PXD030304, Progenetix:CVCL_1353, PubChem_Cell_line:CVCL_1353, Wikidata:Q54900831 |
|
|
CVCL_1353 |
2026-08-29 04:44:37 |
153 |
KYSE-510
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_1354
|
Homo sapiens (Human)
|
Esophageal squamous cell carcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1728357 PMID:7913084 PMID:8575860 PMID:9033652 PMID:11092977 PMID:15172977 PMID:16045545 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
KYSE 510, Kyse-510, KYSE510, Kyse510 |
|
|
CLO:CLO_0007135, EFO:EFO_0006631, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:921, BioSample:SAMN03471052, BioSample:SAMN03473323, BioSample:SAMN10988378, cancercelllines:CVCL_1354, Cell_Model_Passport:SIDM01026, CGH-DB:288-1, CGH-DB:9237-4, ChEMBL-Cells:CHEMBL3308081, ChEMBL-Targets:CHEMBL613868, Cosmic:907321, Cosmic:918535, Cosmic:929527, Cosmic:1123343, Cosmic:2267703, Cosmic:2395007, Cosmic:2698444, Cosmic-CLP:907321, DepMap:ACH-000824, DSMZ:ACC-374, DSMZCellDive:ACC-374, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:907321, GEO:GSM827539, GEO:GSM887254, GEO:GSM888329, GEO:GSM1670024, IARC_TP53:7686, IARC_TP53:21453, JCRB:JCRB1436, LiGeA:CCLE_857, LINCS_LDP:LCL-1555, PharmacoDB:KYSE510_810_2019, PRIDE:PXD030304, Progenetix:CVCL_1354, PubChem_Cell_line:CVCL_1354, Wikidata:Q54900833 |
|
|
CVCL_1354 |
2026-08-29 04:44:37 |
123 |
KYSE-520
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1355
|
Homo sapiens (Human)
|
Esophageal squamous cell carcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1728357 PMID:7913084 PMID:8575860 PMID:9033652 PMID:11092977 PMID:11520067 PMID:12963126 PMID:15172977 PMID:16045545 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30629668 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
KYSE 520, KYSE520, Kyse520, KYSE0520 |
|
|
CLO:CLO_0007136, EFO:EFO_0006632, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:922, BioSample:SAMN03471053, BioSample:SAMN10987932, cancercelllines:CVCL_1355, Cell_Model_Passport:SIDM01025, CGH-DB:289-1, CGH-DB:9238-4, ChEMBL-Cells:CHEMBL3307804, ChEMBL-Targets:CHEMBL612701, CLS:305449, Cosmic:753575, Cosmic:918536, Cosmic:929528, Cosmic:1123344, Cosmic:2009521, Cosmic:2698445, Cosmic-CLP:753575, DepMap:ACH-000637, DSMZ:ACC-371, DSMZCellDive:ACC-371, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:753575, GEO:GSM590307, GEO:GSM827538, GEO:GSM887255, GEO:GSM888330, GEO:GSM1670025, IARC_TP53:7693, JCRB:JCRB1439, LiGeA:CCLE_661, LINCS_LDP:LCL-1556, PharmacoDB:KYSE520_811_2019, PRIDE:PXD030304, Progenetix:CVCL_1355, PubChem_Cell_line:CVCL_1355, Wikidata:Q54900834 |
|
|
CVCL_1355 |
2026-08-29 04:44:37 |
6 |
MCAS
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_3020
|
Homo sapiens (Human)
|
Ovarian mucinous cystadenocarcinoma
|
Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:4056530 PMID:9290701 PMID:11330945 PMID:12417041 PMID:17671176 PMID:20215515 PMID:22246397 PMID:22460905 PMID:22710073 PMID:23839242 PMID:24023729 PMID:25485619 PMID:25846456 PMID:25877200 PMID:26589293 PMID:28196595 PMID:30485824 PMID:30894373 PMID:30971826 PMID:31068700
|
Cancer cell line
|
Female |
|
|
|
CLO:CLO_0037094, EFO:EFO_0006453, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, BioGRID_ORCS_Cell_line:557, BioSample:SAMN03472857, BioSample:SAMN10988206, cancercelllines:CVCL_3020, Cell_Model_Passport:SIDM00008, CGH-DB:343-2, CGH-DB:9356-4, Cosmic:849612, Cosmic:931362, Cosmic:948290, Cosmic:1240171, Cosmic:1707559, Cosmic:2429301, Cosmic:2582802, Cosmic:2674701, DepMap:ACH-000796, EGA:EGAS00001000610, FANTOM5_SSTAR:10784-110H1, GDSC:1240171, GEO:GSM659382, GEO:GSM827228, GEO:GSM851924, GEO:GSM887290, GEO:GSM888365, GEO:GSM1340583, JCRB:JCRB0240, LiGeA:CCLE_290, LINCS_LDP:LCL-1493, PharmacoDB:MCAS_888_2019, Progenetix:CVCL_3020, TKG:TKG 0662, Wikidata:Q54904241 |
|
|
CVCL_3020 |
2026-08-29 04:45:51 |
3 |
MCF-7/HER2-18
Resource Report
Resource Website
|
RRID:CVCL_0U80
|
Homo sapiens (Human)
|
Invasive breast carcinoma of no special type
|
Population: Caucasian.
|
PMID:8095168 PMID:25877200
|
Cancer cell line
|
Female |
MCF-7 HER2-18, MCF-7/Her2-18, MCF7/HER2-clone 18, MCF7/HER2-18, MCF/HER2-18 |
|
|
BioSample:SAMN03471643, cancercelllines:CVCL_0U80, Wikidata:Q54904368 |
cvcl_0031 |
|
CVCL_0U80 |
2026-08-29 04:45:53 |
0 |
MDA-MB-134-VI
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_0617
|
Homo sapiens (Human)
|
Invasive breast lobular carcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: JWGray breast cancer cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: FGFR genetic alteration cell panel (ATCC TCP-1034)., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:730202 PMID:833871 PMID:3518877 PMID:4412247 PMID:6220172 PMID:7842014 PMID:9331070 PMID:9671407 PMID:10862037 PMID:10969801 PMID:11044355 PMID:11343771 PMID:12353263 PMID:12800145 PMID:15677628 PMID:16397213 PMID:16541312 PMID:17157791 PMID:19582160 PMID:19593635 PMID:20164919 PMID:22460905 PMID:23601657 PMID:24094812 PMID:24162158 PMID:24176112 PMID:24425047 PMID:25485619 PMID:25757734 PMID:25877200 PMID:25960936 PMID:26589293 PMID:28196595 PMID:28889351 PMID:30228172 PMID:30894373 PMID:31068700
|
Cancer cell line
|
Female |
MDA-MB-134 VI, MDA MB 134VI, MDA-MB-134VI, MDAMB134VI, MDA-MB-134, MDAMB134, MDA-134, MDA134, MM134, MD Anderson-Metastatic Breast-134-VI |
|
|
CLO:CLO_0007631, EFO:EFO_0001205, CLDB:cl3398, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-TABM-157, ATCC:HTB-23, BioSample:SAMN03471473, BioSample:SAMN10988465, cancercelllines:CVCL_0617, CCRID:1101HUM-PUMC000380, Cell_Model_Passport:SIDM00005, ChEMBL-Cells:CHEMBL3308340, ChEMBL-Targets:CHEMBL2366242, Cosmic:687491, Cosmic:735125, Cosmic:809233, Cosmic:904374, Cosmic:908119, Cosmic:934525, Cosmic:997933, Cosmic:1000129, Cosmic:1046947, Cosmic:1047696, Cosmic:1090333, Cosmic:1136347, Cosmic:1152519, Cosmic:1287908, Cosmic:1289392, Cosmic:1603216, DepMap:ACH-000044, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:908119, GEO:GSM115107, GEO:GSM186432, GEO:GSM186433, GEO:GSM186434, GEO:GSM217584, GEO:GSM219959, GEO:GSM320180, GEO:GSM350523, GEO:GSM421870, GEO:GSM783960, GEO:GSM847398, GEO:GSM847491, GEO:GSM887292, GEO:GSM888367, GEO:GSM1053695, GEO:GSM1172886, GEO:GSM1172976, GEO:GSM1215268, GEO:GSM1226522, GEO:GSM1226523, GEO:GSM1226524, GEO:GSM1226525, GEO:GSM1226526, GEO:GSM1226527, GEO:GSM1226528, GEO:GSM1226529, GEO:GSM1226530, GEO:GSM1226531, GEO:GSM1226532, GEO:GSM1226533, GEO:GSM1226534, GEO:GSM1226535, GEO:GSM1226536, GEO:GSM1226537, GEO:GSM1226538, GEO:GSM1226539, GEO:GSM1226540, GEO:GSM1226541, GEO:GSM1238133, GEO:GSM1374647, GEO:GSM1401662, GEO:GSM1661981, GEO:GSM1670078, IARC_TP53:18375, IZSLER:BS TCL 236, LiGeA:CCLE_784, LINCS_HMS:50327, LINCS_LDP:LCL-1316, PharmacoDB:MDAMB134VI_897_2019, Progenetix:CVCL_0617, PubChem_Cell_line:CVCL_0617, SLKBase:3582, Wikidata:Q54904577 |
|
|
CVCL_0617 |
2026-08-29 04:46:01 |
22 |
MDA-MB-231
Resource Report
Resource Website
10000+ mentions
Possibly Discontinued
|
RRID:CVCL_0062
|
Homo sapiens (Human)
|
Breast adenocarcinoma
|
Anecdotal: Used in a study utilising the fruit fly's olfactory system to detect cancer cells (PubMed=24389870)., Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: JWGray breast cancer cell line panel., Part of: JFCR45 cancer cell line panel., Part of: JFCR39 cancer cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: ENCODE project common cell types; tier 3., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Triple negative breast cancer (TNBC) cell line.
|
PMID:77569 PMID:730202 PMID:833871 PMID:1000504 PMID:1000505 PMID:1000506 PMID:1961733 PMID:3335022 PMID:3518877 PMID:4412247 PMID:6582512 PMID:6935474 PMID:7000337 PMID:7272986 PMID:7459858 PMID:7902062 PMID:8824553 PMID:9331090 PMID:9670966 PMID:9671407 PMID:9815641 PMID:10700174 PMID:10969801 PMID:11499871 PMID:11687795 PMID:11697798 PMID:12068308 PMID:12353263 PMID:12661003 PMID:12800145 PMID:15153330 PMID:15677628 PMID:15748285 PMID:15767549 PMID:15900046 PMID:16049480 PMID:16142302 PMID:16397213 PMID:16417655 PMID:16541312 PMID:17088437 PMID:17157791 PMID:17334996 PMID:18277095 PMID:18386134 PMID:18516279 PMID:18714363 PMID:19372543 PMID:19582160 PMID:19593635 PMID:20070913 PMID:20164919 PMID:21378333 PMID:21778573 PMID:22068913 PMID:22336246 PMID:22347499 PMID:22384151 PMID:22460905 PMID:22585861 PMID:22628656 PMID:23151021 PMID:23601657 PMID:23856246 PMID:23933261 PMID:24009699 PMID:24094812 PMID:24162158 PMID:24176112 PMID:24279929 PMID:24389870 PMID:24670534 PMID:25485619 PMID:25877200 PMID:25892236 PMID:25960936 PMID:26055192 PMID:26218769 PMID:26589293 PMID:26649326 PMID:27331101 PMID:27377824 PMID:27397505 PMID:27807467 PMID:28196595 PMID:28287265 PMID:28889351 PMID:29273624 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31092827 PMID:31733513 PMID:31978347 PMID:32782317 PMID:34238275 PMID:34320349 PMID:35042871 PMID:35666001 PMID:35839778 PMID:38861359
|
Cancer cell line
|
Female |
MDA_MB_231, MDA-MB 231, MDA.MB.231, MDA MB 231, MDA MB231, MDA Mb231, MDA-MB231, MDAMB-231, MDAMB231, MDA-231, MDA-231P, MDA231, MDA231-BRE, MB231, MD Anderson-Metastatic Breast-231 |
|
|
BTO:BTO_0000815, CLO:CLO_0007634, CLO:CLO_0037291, EFO:EFO_0001209, MCCL:MCC:0000313, CLDB:cl3402, CLDB:cl3404, CLDB:cl3405, CLDB:cl4945, AddexBio:C0006002/58, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-11134, ArrayExpress:E-TABM-157, ArrayExpress:E-TABM-244, ATCC:CRM-HTB-26, ATCC:HTB-26, BCRC:60425, BCRJ:0164, BioGRID_ORCS_Cell_line:554, BioSample:SAMN03472205, BioSample:SAMN05292460, BioSample:SAMN07710033, BioSample:SAMN07710034, BioSample:SAMN07710035, BioSample:SAMN07710036, BioSample:SAMN07710037, BioSample:SAMN07710038, BioSample:SAMN07710039, BioSample:SAMN10987764, cancercelllines:CVCL_0062, CCRID:1101HUM-PUMC000014, CCRID:3101HUMSCSP5043, CCRID:3101HUMTCHu227, CCRID:4201HUM-CCTCC00297, CCRID:5301HUM-KCB07076YJ, CCTCC:GDC0297, Cell_Model_Passport:SIDM00146, ChEMBL-Cells:CHEMBL3307960, ChEMBL-Targets:CHEMBL400, CLS:300275, Cosmic:687494, Cosmic:871146, Cosmic:875878, Cosmic:877450, Cosmic:894087, Cosmic:897423, Cosmic:904377, Cosmic:905960, Cosmic:934536, Cosmic:944294, Cosmic:974235, Cosmic:991324, Cosmic:997929, Cosmic:1010924, Cosmic:1018477, Cosmic:1027053, Cosmic:1044226, Cosmic:1046950, Cosmic:1047693, Cosmic:1071900, Cosmic:1092613, Cosmic:1136369, Cosmic:1152528, Cosmic:1175833, Cosmic:1176602, Cosmic:1176636, Cosmic:1183773, Cosmic:1219444, Cosmic:1287926, Cosmic:1289395, Cosmic:1305383, Cosmic:1309003, Cosmic:1312370, Cosmic:1434952, Cosmic:1436032, Cosmic:1466805, Cosmic:1477428, Cosmic:1481426, Cosmic:1524347, Cosmic:1571793, Cosmic:1609458, Cosmic:1927242, Cosmic:1945862, Cosmic:1998455, Cosmic:2009512, Cosmic:2036667, Cosmic:2164997, Cosmic:2301528, Cosmic:2318377, Cosmic:2361355, Cosmic:2560256, Cosmic-CLP:905960, DepMap:ACH-000768, DSMZ:ACC-732, DSMZCellDive:ACC-732, ECACC:92020424, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, FCS-free:253-2-521-2-3-3, GDSC:905960, GEO:GSM812, GEO:GSM2124, GEO:GSM49953, GEO:GSM49954, GEO:GSM50184, GEO:GSM50248, GEO:GSM69194, GEO:GSM155213, GEO:GSM185093, GEO:GSM185094, GEO:GSM274653, GEO:GSM344349, GEO:GSM344399, GEO:GSM350547, GEO:GSM378148, GEO:GSM388213, GEO:GSM421873, GEO:GSM459713, GEO:GSM481304, GEO:GSM587393, GEO:GSM587394, GEO:GSM750781, GEO:GSM799321, GEO:GSM799384, GEO:GSM820814, GEO:GSM820815, GEO:GSM820816, GEO:GSM839034, GEO:GSM844594, GEO:GSM844595, GEO:GSM847036, GEO:GSM847401, GEO:GSM887295, GEO:GSM888370, GEO:GSM967818, GEO:GSM1008905, GEO:GSM1053716, GEO:GSM1153390, GEO:GSM1172889, GEO:GSM1172979, GEO:GSM1181242, GEO:GSM1181365, GEO:GSM1214569, GEO:GSM1238120, GEO:GSM1374651, GEO:GSM1374652, GEO:GSM1401658, GEO:GSM1613823, GEO:GSM1670080, GEO:GSM1833624, GEO:GSM2095710, GEO:GSM2095711, GEO:GSM2124643, GEO:GSM2258848, GEO:GSM2258849, GEO:GSM2258850, GEO:GSM2258851, GEO:GSM2258852, GEO:GSM2258853, GEO:GSM2258854, GEO:GSM2258855, GEO:GSM2258856, GEO:GSM2258857, GEO:GSM2258858, GEO:GSM2258859, GEO:GSM2258860, GEO:GSM2258861, GEO:GSM2258862, GEO:GSM2258863, GEO:GSM2258864, GEO:GSM2258865, GEO:GSM2258932, GEO:GSM2258933, GEO:GSM2258934, GEO:GSM3161720, GEO:GSM3161721, IARC_TP53:6, IBRC:C10684, ICLC:HTL99004, IZSLER:BS TCL 223, KCB:KCB 200776YJ, KCLB:30026, LiGeA:CCLE_752, LINCS_HMS:50058, LINCS_LDP:LCL-1461, Lonza:815, MetaboLights:MTBLS337, MetaboLights:MTBLS387, MetaboLights:MTBLS678, NCBI_Iran:C578, NCI-DTP:MDA-MB-231, PharmacoDB:MDAMB231_900_2019, PRIDE:PXD000239, PRIDE:PXD000397, PRIDE:PXD000691, PRIDE:PXD000914, PRIDE:PXD001553, PRIDE:PXD002192, PRIDE:PXD002649, PRIDE:PXD003539, PRIDE:PXD005292, PRIDE:PXD005942, PRIDE:PXD005946, PRIDE:PXD008222, PRIDE:PXD010634, PRIDE:PXD028400, PRIDE:PXD030304, Progenetix:CVCL_0062, PubChem_Cell_line:CVCL_0062, SKY/M-FISH/CGH:2815, SLKBase:3575, TOKU-E:2394, Ubigene:YC-D005, Wikidata:Q17577870 |
|
|
CVCL_0062 |
2026-08-29 04:46:01 |
20024 |
MDA-MB-157
Resource Report
Resource Website
100+ mentions
Possibly Discontinued
|
RRID:CVCL_0618
|
Homo sapiens (Human)
|
Breast carcinoma
|
Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: JWGray breast cancer cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Triple negative breast cancer (TNBC) cell line.
|
PMID:730202 PMID:833871 PMID:1961733 PMID:3518877 PMID:4412247 PMID:4471183 PMID:9671407 PMID:10862037 PMID:10969801 PMID:11044355 PMID:11343771 PMID:12353263 PMID:12800145 PMID:15153330 PMID:15677628 PMID:16397213 PMID:16541312 PMID:17157791 PMID:19582160 PMID:19593635 PMID:20164919 PMID:20215515 PMID:20679594 PMID:21778573 PMID:22460905 PMID:22585861 PMID:23151021 PMID:23601657 PMID:24094812 PMID:24176112 PMID:25485619 PMID:25877200 PMID:25892236 PMID:25960936 PMID:26589293 PMID:27397505 PMID:28196595 PMID:28287265 PMID:28889351 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
MDA-MB157, MDAMB157, MDA-157, MDA157, MB 157, MB157, MD Anderson-Metastatic Breast-157 |
|
|
BTO:BTO_0006218, CLO:CLO_0007544, CLO:CLO_0007632, EFO:EFO_0001206, CLDB:cl3400, CLDB:cl3401, AddexBio:C0006020/4986, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-TABM-157, ATCC:CRL-7721, ATCC:HTB-24, BCRJ:0319, BioGRID_ORCS_Cell_line:556, BioSample:SAMN03472739, BioSample:SAMN03473083, BioSample:SAMN10988196, cancercelllines:CVCL_0618, CCRID:1101HUM-PUMC000077, Cell_Model_Passport:SIDM00529, ChEMBL-Cells:CHEMBL3308759, ChEMBL-Targets:CHEMBL1075496, CLS:305280, Cosmic:687492, Cosmic:809234, Cosmic:871144, Cosmic:897421, Cosmic:904375, Cosmic:925338, Cosmic:934535, Cosmic:979714, Cosmic:1010921, Cosmic:1017166, Cosmic:1018462, Cosmic:1027052, Cosmic:1044207, Cosmic:1044228, Cosmic:1046954, Cosmic:1047692, Cosmic:1136372, Cosmic:1176640, Cosmic:1287919, Cosmic:1289393, Cosmic:1477429, Cosmic:1523776, Cosmic:1603217, Cosmic:1609468, Cosmic:1995501, Cosmic:2009506, Cosmic:2301527, Cosmic-CLP:925338, DepMap:ACH-000621, DepMap:ACH-001120, ECACC:92020422, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:925338, GEO:GSM73731, GEO:GSM115112, GEO:GSM186435, GEO:GSM186436, GEO:GSM217585, GEO:GSM219942, GEO:GSM350548, GEO:GSM421871, GEO:GSM783948, GEO:GSM783970, GEO:GSM827192, GEO:GSM844591, GEO:GSM847399, GEO:GSM847492, GEO:GSM887293, GEO:GSM888368, GEO:GSM1053729, GEO:GSM1172881, GEO:GSM1172977, GEO:GSM1238139, GEO:GSM1374648, GEO:GSM1374649, GEO:GSM1401671, GEO:GSM1670079, IARC_TP53:18370, LiGeA:CCLE_925, LINCS_HMS:50324, LINCS_HMS:50328, LINCS_LDP:LCL-1484, LINCS_LDP:LCL-1916, PharmacoDB:MDAMB157_898_2019, PRIDE:PXD005292, PRIDE:PXD008222, PRIDE:PXD030304, Progenetix:CVCL_0618, PubChem_Cell_line:CVCL_0618, SLKBase:3596, Wikidata:Q54904578 |
|
|
CVCL_0618 |
2026-08-29 04:46:01 |
416 |
MDA-MB-468
Resource Report
Resource Website
1000+ mentions
|
RRID:CVCL_0419
|
Homo sapiens (Human)
|
Breast adenocarcinoma
|
Population: African American., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: JWGray breast cancer cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: EGFR genetic alteration cell panel (ATCC TCP-1027)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Triple negative breast cancer (TNBC) cell line.
|
PMID:730202 PMID:1961733 PMID:3518877 PMID:9671407 PMID:10969801 PMID:11414198 PMID:12353263 PMID:12800145 PMID:15153330 PMID:15677628 PMID:16397213 PMID:16541312 PMID:17157791 PMID:18262045 PMID:18516279 PMID:19582160 PMID:19593635 PMID:20070913 PMID:20164919 PMID:21778573 PMID:22384151 PMID:22460905 PMID:22585861 PMID:22628656 PMID:23151021 PMID:23601657 PMID:23856246 PMID:24094812 PMID:24162158 PMID:24176112 PMID:24279929 PMID:25485619 PMID:25699542 PMID:25877200 PMID:25892236 PMID:25960936 PMID:26589293 PMID:27377824 PMID:27397505 PMID:27807467 PMID:28196595 PMID:28287265 PMID:28889351 PMID:29273624 PMID:30613774 PMID:30787054 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:32576280 PMID:34703030 PMID:35839778 PMID:38861359 PMID:40300663
|
Cancer cell line
|
Female |
MDA-MB 468, MDA-MB468, MDAMB468, MDA-468, MDA468, MB468, MD Anderson-Metastatic Breast-468 |
|
|
BTO:BTO_0001570, CLO:CLO_0007641, EFO:EFO_0001216, MCCL:MCC:0000316, CLDB:cl4973, AddexBio:C0006003/4673, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-6647, ArrayExpress:E-TABM-157, ArrayExpress:E-TABM-244, ATCC:HTB-132, BCRJ:0166, BioGRID_ORCS_Cell_line:551, BioSample:SAMN03473056, BioSample:SAMN05292454, BioSample:SAMN10988340, cancercelllines:CVCL_0419, CCRID:1101HUM-PUMC000249, CCRID:3101HUMTCHu136, Cell_Model_Passport:SIDM00628, ChEMBL-Cells:CHEMBL3308424, ChEMBL-Targets:CHEMBL614335, CLS:300279, Cosmic:809241, Cosmic:850823, Cosmic:871149, Cosmic:877448, Cosmic:897427, Cosmic:904384, Cosmic:908123, Cosmic:923061, Cosmic:934530, Cosmic:949192, Cosmic:991327, Cosmic:997921, Cosmic:1000125, Cosmic:1010920, Cosmic:1017167, Cosmic:1018467, Cosmic:1044224, Cosmic:1046929, Cosmic:1047691, Cosmic:1136363, Cosmic:1152526, Cosmic:1176635, Cosmic:1287918, Cosmic:1289402, Cosmic:1305384, Cosmic:1309004, Cosmic:1477427, Cosmic:1523775, Cosmic:1524344, Cosmic:1571795, Cosmic:1603223, Cosmic:1609465, Cosmic:1998490, Cosmic:2009514, Cosmic:2036673, Cosmic:2164999, Cosmic:2301533, Cosmic:2318380, Cosmic:2361357, Cosmic:2668276, Cosmic-CLP:908123, DepMap:ACH-000849, DSMZ:ACC-738, DSMZCellDive:ACC-738, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:908123, GEO:GSE184543, GEO:GSM75169, GEO:GSM185095, GEO:GSM185096, GEO:GSM217591, GEO:GSM219929, GEO:GSM344356, GEO:GSM344406, GEO:GSM350502, GEO:GSM388214, GEO:GSM421880, GEO:GSM459714, GEO:GSM459722, GEO:GSM466357, GEO:GSM783955, GEO:GSM847418, GEO:GSM847497, GEO:GSM887301, GEO:GSM888376, GEO:GSM1008911, GEO:GSM1053727, GEO:GSM1172984, GEO:GSM1214565, GEO:GSM1238123, GEO:GSM1374663, GEO:GSM1374664, GEO:GSM1374665, GEO:GSM1401650, GEO:GSM1556177, GEO:GSM1556178, GEO:GSM1556179, GEO:GSM1556180, GEO:GSM1556181, GEO:GSM1661984, GEO:GSM1670087, GEO:GSM1833629, GEO:GSM2124671, GEO:GSM2258884, GEO:GSM2258885, GEO:GSM2258886, GEO:GSM2258887, GEO:GSM2258888, GEO:GSM2258889, GEO:GSM2258890, GEO:GSM2258891, GEO:GSM2258892, GEO:GSM2258893, GEO:GSM2258894, GEO:GSM2258895, GEO:GSM2258896, GEO:GSM2258897, GEO:GSM2258898, GEO:GSM2258899, GEO:GSM2258900, GEO:GSM2258901, GEO:GSM2258941, GEO:GSM2258942, GEO:GSM2258943, IARC_TP53:94, IBRC:C10095, ICLC:HTL99024, KCB:KCB 2011114YJ, LiGeA:CCLE_336, LINCS_HMS:50335, LINCS_LDP:LCL-1471, Lonza:809, NCBI_Iran:C208, NCI-DTP:MDA-MB-468, PharmacoDB:MDAMB468_907_2019, PRIDE:PXD001680, PRIDE:PXD005295, PRIDE:PXD008222, PRIDE:PXD022325, PRIDE:PXD030304, Progenetix:CVCL_0419, PubChem_Cell_line:CVCL_0419, SLKBase:3578, TOKU-E:2401, TOKU-E:3604, Ubigene:YC-D009, Wikidata:Q16880225 |
|
|
CVCL_0419 |
2026-08-29 04:46:02 |
3971 |
MDA-MB-436
Resource Report
Resource Website
500+ mentions
|
RRID:CVCL_0623
|
Homo sapiens (Human)
|
Invasive breast carcinoma of no special type
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: JWGray breast cancer cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Triple negative breast cancer (TNBC) cell line.
|
PMID:730202 PMID:1961733 PMID:3518877 PMID:7272986 PMID:9288768 PMID:9823299 PMID:10862037 PMID:10969801 PMID:11343771 PMID:15677628 PMID:16397213 PMID:16541312 PMID:17157791 PMID:18516279 PMID:19582160 PMID:19593635 PMID:21778573 PMID:22460905 PMID:22585861 PMID:23151021 PMID:23601657 PMID:24094812 PMID:24162158 PMID:24176112 PMID:25485619 PMID:25877200 PMID:25892236 PMID:26589293 PMID:27397505 PMID:28196595 PMID:28287265 PMID:28889351 PMID:29273624 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
MDA_MB_436, MDA MB 436, MDA-Mb-436, MDA-MB436, MDAMB436, MDA-436, MDA436, MB436, MD Anderson-Metastatic Breast-436 |
|
|
BTO:BTO_0001568, CLO:CLO_0007639, EFO:EFO_0001214, CLDB:cl7218, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-TABM-157, ArrayExpress:E-TABM-244, ATCC:HTB-130, BioGRID_ORCS_Cell_line:553, BioSample:SAMN03471588, BioSample:SAMN03472712, BioSample:SAMN10987901, cancercelllines:CVCL_0623, CCRID:1101HUM-PUMC000352, CCRID:3101HUMTCHu184, Cell_Model_Passport:SIDM00629, ChEMBL-Cells:CHEMBL4295382, ChEMBL-Targets:CHEMBL4296465, CLS:300278, Cosmic:809240, Cosmic:871156, Cosmic:897425, Cosmic:904382, Cosmic:934528, Cosmic:949191, Cosmic:979718, Cosmic:1010926, Cosmic:1017165, Cosmic:1027055, Cosmic:1044206, Cosmic:1044222, Cosmic:1046957, Cosmic:1071902, Cosmic:1176604, Cosmic:1287923, Cosmic:1289400, Cosmic:1309008, Cosmic:1434955, Cosmic:1609474, Cosmic:2009513, Cosmic:2164998, Cosmic:2361353, Cosmic-CLP:1240172, DepMap:ACH-000573, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1240172, GEO:GSM115100, GEO:GSM149985, GEO:GSM149993, GEO:GSM150001, GEO:GSM217589, GEO:GSM344354, GEO:GSM344404, GEO:GSM350541, GEO:GSM421878, GEO:GSM783954, GEO:GSM844600, GEO:GSM844601, GEO:GSM845397, GEO:GSM847416, GEO:GSM847496, GEO:GSM887299, GEO:GSM888374, GEO:GSM1008909, GEO:GSM1053725, GEO:GSM1172982, GEO:GSM1214583, GEO:GSM1238135, GEO:GSM1374658, GEO:GSM1374659, GEO:GSM1401656, GEO:GSM1670085, GEO:GSM2258866, GEO:GSM2258867, GEO:GSM2258868, GEO:GSM2258869, GEO:GSM2258870, GEO:GSM2258871, GEO:GSM2258872, GEO:GSM2258873, GEO:GSM2258874, GEO:GSM2258875, GEO:GSM2258876, GEO:GSM2258877, GEO:GSM2258878, GEO:GSM2258879, GEO:GSM2258880, GEO:GSM2258881, GEO:GSM2258882, GEO:GSM2258883, GEO:GSM2258938, GEO:GSM2258939, GEO:GSM2258940, GEO:GSM3161722, GEO:GSM3161723, IARC_TP53:18371, IARC_TP53:26994, ICLC:HTL11005, IZSLER:BS TCL 246, LiGeA:CCLE_254, LINCS_HMS:50333, LINCS_LDP:LCL-1470, PharmacoDB:MDAMB436_905_2019, PRIDE:PXD005292, PRIDE:PXD008222, PRIDE:PXD030304, Progenetix:CVCL_0623, PubChem_Cell_line:CVCL_0623, SLKBase:3609, TOKU-E:2399, Wikidata:Q54904639 |
|
|
CVCL_0623 |
2026-08-29 04:46:02 |
839 |
MDA-MB-453
Resource Report
Resource Website
1000+ mentions
|
RRID:CVCL_0418
|
Homo sapiens (Human)
|
Breast adenocarcinoma
|
Population: Caucasian., Part of: PI3K genetic alteration cell panel (ATCC TCP-1028)., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: JWGray breast cancer cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Triple negative breast cancer (TNBC) cell line.
|
PMID:730202 PMID:1961733 PMID:3518877 PMID:9671407 PMID:9815641 PMID:10969801 PMID:11687795 PMID:11789735 PMID:12353263 PMID:12800145 PMID:16142302 PMID:16397213 PMID:16541312 PMID:17157791 PMID:18516279 PMID:19582160 PMID:19593635 PMID:20164919 PMID:20215515 PMID:21378333 PMID:22121396 PMID:22414580 PMID:22460905 PMID:22585861 PMID:22719059 PMID:23601657 PMID:24094812 PMID:24176112 PMID:25485619 PMID:25877200 PMID:25892236 PMID:25984343 PMID:26218769 PMID:26589293 PMID:27397505 PMID:28196595 PMID:28889351 PMID:30787054 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
MDA-MB 453, MDA MB 453, MDA-MB453, MDAMB453, MDA-453, MDA453, MD Anderson-Metastatic Breast-453 |
|
|
BTO:BTO_0001908, CLO:CLO_0007640, CLO:CLO_0050867, EFO:EFO_0001215, MCCL:MCC:0000315, CLDB:cl3411, CLDB:cl7187, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-TABM-157, ArrayExpress:E-TABM-244, ATCC:HTB-131, BCRC:60429, BioGRID_ORCS_Cell_line:552, BioSample:SAMN01821576, BioSample:SAMN01821647, BioSample:SAMN03472899, BioSample:SAMN10988263, cancercelllines:CVCL_0418, CCRID:1101HUM-PUMC000016, CCRID:3101HUMSCSP5044, CCRID:3101HUMTCHu233, Cell_Model_Passport:SIDM00272, ChEMBL-Cells:CHEMBL3307596, ChEMBL-Targets:CHEMBL614334, CLS:305042, Cosmic:687497, Cosmic:871157, Cosmic:897426, Cosmic:904383, Cosmic:908122, Cosmic:923060, Cosmic:934529, Cosmic:979712, Cosmic:991326, Cosmic:997920, Cosmic:1010927, Cosmic:1018468, Cosmic:1027056, Cosmic:1044223, Cosmic:1046931, Cosmic:1047694, Cosmic:1129656, Cosmic:1136356, Cosmic:1152522, Cosmic:1176651, Cosmic:1287911, Cosmic:1289401, Cosmic:1308995, Cosmic:1434956, Cosmic:1524345, Cosmic:1601924, Cosmic:1603222, Cosmic:1609457, Cosmic:2165012, Cosmic:2301532, Cosmic:2318375, Cosmic:2564832, Cosmic:2820307, Cosmic-CLP:908122, DepMap:ACH-000910, DSMZ:ACC-65, DSMZCellDive:ACC-65, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, FANTOM5_SSTAR:10419-106C5, GDSC:908122, GEO:GSM813, GEO:GSM115117, GEO:GSM217590, GEO:GSM219956, GEO:GSM274656, GEO:GSM344355, GEO:GSM344405, GEO:GSM350530, GEO:GSM421879, GEO:GSM481307, GEO:GSM783928, GEO:GSM844602, GEO:GSM847417, GEO:GSM887300, GEO:GSM888375, GEO:GSM1008910, GEO:GSM1053710, GEO:GSM1172983, GEO:GSM1264071, GEO:GSM1264075, GEO:GSM1264113, GEO:GSM1264117, GEO:GSM1374660, GEO:GSM1374661, GEO:GSM1374662, GEO:GSM1384316, GEO:GSM1401667, GEO:GSM1421431, GEO:GSM1661983, GEO:GSM1664568, GEO:GSM1670086, IARC_TP53:762, IARC_TP53:21146, IARC_TP53:26995, ICLC:HTL01013, IGRhCellID:MDAMB453, IZSLER:BS TCL 247, KCLB:30131, LiGeA:CCLE_768, LINCS_HMS:50334, LINCS_LDP:LCL-1485, Lonza:837, NCBI_Iran:C214, PharmacoDB:MDAMB453_906_2019, PRIDE:PXD000309, PRIDE:PXD008222, PRIDE:PXD030304, Progenetix:CVCL_0418, PubChem_Cell_line:CVCL_0418, RCB:RCB1192, SLKBase:3613, Wikidata:Q54904642 |
|
|
CVCL_0418 |
2026-08-29 04:46:02 |
1504 |
MX-1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_4774
|
Homo sapiens (Human)
|
Breast carcinoma
|
Characteristics: Established from a tumor xenograft established in atyhmic mice., Population: Caucasian., Part of: JWGray breast cancer cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:10969801 PMID:24176112 PMID:25485619 PMID:25877200 PMID:25960936 PMID:26589293 PMID:29045385
|
Cancer cell line
|
Female |
MX1, MXI |
|
|
BTO:BTO_0004179, CLO:CLO_0009915, EFO:EFO_0006457, ArrayExpress:E-MTAB-2706, BioSample:SAMN03472921, ChEMBL-Cells:CHEMBL3308046, ChEMBL-Targets:CHEMBL613704, CLS:300296, DepMap:ACH-002328, EGA:EGAS00001000610, EGA:EGAS00001002554, GEO:GSM844611, GEO:GSM844612, GEO:GSM844613, GEO:GSM845398, GEO:GSM1172893, GEO:GSM1172987, LINCS_HMS:51090, LINCS_LDP:LCL-2072, NCI-DTP:MX-1, PharmacoDB:MX1_973_2019, PubChem_Cell_line:CVCL_4774, Wikidata:Q54907134 |
|
|
CVCL_4774 |
2026-08-29 04:47:15 |
5 |
NALM-6
Resource Report
Resource Website
500+ mentions
|
RRID:CVCL_0092
|
Homo sapiens (Human)
|
Adult B acute lymphoblastic leukemia
|
Population: Caucasian., Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel., Part of: MD Anderson Cell Lines Project., Part of: LL-100 blood cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:83966 PMID:155647 PMID:2140233 PMID:2415623 PMID:2783384 PMID:2939141 PMID:2985879 PMID:3159941 PMID:3874327 PMID:8847894 PMID:9067587 PMID:9510473 PMID:9680106 PMID:9738977 PMID:10490826 PMID:10695022 PMID:10739008 PMID:11021758 PMID:11226526 PMID:11416159 PMID:11986953 PMID:15843827 PMID:16405397 PMID:16408098 PMID:16969076 PMID:20103924 PMID:20164919 PMID:20215515 PMID:20575032 PMID:20922763 PMID:22460905 PMID:23596518 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27397505 PMID:28196595 PMID:29786757 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:31160637 PMID:31243274 PMID:31305009 PMID:31978347 PMID:34823530 PMID:35124168 PMID:35354797 PMID:35839778
|
Cancer cell line
|
Male |
Nalm-6, NALM 6, Nalm 6, NALM6, Nalm6, NALM-6-M1 |
|
|
BTO:BTO_0003288, CLO:CLO_0007938, CLO:CLO_0050970, EFO:EFO_0002245, CLDB:cl3631, CLDB:cl3632, AddexBio:C0003030/5015, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, BioGRID_ORCS_Cell_line:273, BioSample:SAMN03472035, BioSample:SAMN03473163, BioSample:SAMN03473413, BioSample:SAMN10988491, cancercelllines:CVCL_0092, Cell_Model_Passport:SIDM00429, ChEMBL-Cells:CHEMBL3307559, ChEMBL-Targets:CHEMBL614187, CLS:300297, Cosmic:801722, Cosmic:850385, Cosmic:889112, Cosmic:908158, Cosmic:919147, Cosmic:991553, Cosmic:998708, Cosmic:999748, Cosmic:1012106, Cosmic:1037711, Cosmic:1070706, Cosmic:1093787, Cosmic:1130246, Cosmic:1191699, Cosmic:1483361, Cosmic:1509198, Cosmic:1524810, Cosmic:2491082, Cosmic:2649232, Cosmic-CLP:908158, DepMap:ACH-000938, DSMZ:ACC-128, DSMZCellDive:ACC-128, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, FANTOM5_SSTAR:10534-107G3, GDSC:908158, GEO:GSM236797, GEO:GSM236833, GEO:GSM887347, GEO:GSM888423, GEO:GSM1670142, GEO:GSM5137734, IARC_TP53:21527, IGRhCellID:NALM6, LiGeA:CCLE_665, LINCS_LDP:LCL-1007, Lonza:812, NCBI_Iran:C212, PharmacoDB:NALM6_980_2019, PRIDE:PXD023662, PRIDE:PXD030304, Progenetix:CVCL_0092, PubChem_Cell_line:CVCL_0092, RCB:RCB1933, TKG:TKG 0413, Wikidata:Q54907426 |
|
|
CVCL_0092 |
2026-08-29 04:47:27 |
531 |
MOLP-2
Resource Report
Resource Website
|
RRID:CVCL_2123
|
Homo sapiens (Human)
|
Plasma cell myeloma
|
Characteristics: Produces IgD lambda., Population: Japanese., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8148313 PMID:10936422 PMID:15215163 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:30285677 PMID:30894373 PMID:31068700 PMID:32123307
|
Cancer cell line
|
Male |
MOLP2 |
|
|
EFO:EFO_0006653, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, BioSample:SAMN03472938, BioSample:SAMN10988424, cancercelllines:CVCL_2123, Cell_Model_Passport:SIDM01690, CGH-DB:9146-4, DepMap:ACH-000453, DSMZ:ACC-607, DSMZCellDive:ACC-607, EGA:EGAS00001000610, GEO:GSM562815, GEO:GSM887332, GEO:GSM888408, IARC_TP53:28365, JCRB:JCRB1820, LiGeA:CCLE_676, PharmacoDB:MOLP2_953_2019, Progenetix:CVCL_2123, Wikidata:Q54906334 |
|
|
CVCL_2123 |
2026-08-29 04:46:50 |
0 |
MOG-G-UVW
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_2614
|
Homo sapiens (Human)
|
Anaplastic astrocytoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:3254724 PMID:7518347 PMID:7591247 PMID:20215515 PMID:25877200 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
MOG-GUVW, MOGGUVW, GO-G-UVW, G-UVW, UVW, Medical Oncology Glascow-Glioma-UVW |
|
|
CLO:CLO_0007818, CLDB:cl3513, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:945, BioSample:SAMN03470987, BioSample:SAMN10988296, cancercelllines:CVCL_2614, Cell_Model_Passport:SIDM00504, ChEMBL-Cells:CHEMBL3308137, ChEMBL-Targets:CHEMBL1075508, Cosmic:908145, Cosmic:2367539, Cosmic-CLP:908145, DepMap:ACH-001126, ECACC:86022703, EGA:EGAS00001000978, GDSC:90815, GEO:GSM827433, GEO:GSM1374687, GEO:GSM1670123, IARC_TP53:21510, LINCS_LDP:LCL-1397, PharmacoDB:MOGGUVW_949_2019, PRIDE:PXD030304, Progenetix:CVCL_2614, PubChem_Cell_line:CVCL_2614, Wikidata:Q54906313 |
|
|
CVCL_2614 |
2026-08-29 04:46:49 |
1 |
MOLT-3
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_0624
|
Homo sapiens (Human)
|
Adult T acute lymphoblastic leukemia
|
Karyotypic information: Hypertetraploid karyotype (ATCC=CRL-1552)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:327080 PMID:1086134 PMID:2846092 PMID:2985879 PMID:3159941 PMID:3518877 PMID:3856477 PMID:3874327 PMID:4547172 PMID:4567231 PMID:6220172 PMID:6600440 PMID:6978176 PMID:7630190 PMID:8547074 PMID:8608962 PMID:9738977 PMID:9787181 PMID:9933131 PMID:10739008 PMID:11986953 PMID:12623853 PMID:15472075 PMID:17170727 PMID:20215515 PMID:25877200 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:35354797
|
Cancer cell line
|
Male |
Molt-3, MOLT 3, Molt 3, MOLT3, Molt3 |
|
|
BTO:BTO_0001081, CLO:CLO_0007824, CLO:CLO_0051008, EFO:EFO_0005265, CLDB:cl3519, CLDB:cl3521, CLDB:cl3522, CLDB:cl3523, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2770, ATCC:CRL-1552, BCRC:60106, BEI_Resources:ARP-12187, BioSample:SAMN03470846, BioSample:SAMN03471394, BioSample:SAMN03472164, BioSample:SAMN03473404, BioSample:SAMN10989586, cancercelllines:CVCL_0624, Cell_Model_Passport:SIDM00153, ChEMBL-Cells:CHEMBL3307556, ChEMBL-Targets:CHEMBL614176, CLS:300116, Cosmic:724815, Cosmic:850193, Cosmic:913410, Cosmic:999756, Cosmic:1191701, Cosmic:1281377, Cosmic:1524845, Cosmic:2301561, Cosmic:2361367, Cosmic:2602923, DepMap:ACH-000964, DSMZ:ACC-84, DSMZCellDive:ACC-84, ECACC:90021901, GEO:GSM236793, GEO:GSM236829, GEO:GSM5137730, IGRhCellID:MOLT3, IZSLER:BS TCL 44, JCRB:JCRB9048, LiGeA:CCLE_717, PharmacoDB:MOLT3_957_2019, PRIDE:PXD023662, Progenetix:CVCL_0624, PubChem_Cell_line:CVCL_0624, RCB:RCB1164, Wikidata:Q54906351 |
|
|
CVCL_0624 |
2026-08-29 04:46:50 |
7 |